STAT1 and pulmonary arterial hypertension: The IFN-STAT1 pathway also promotes the release of monocyte chemoattractant protein −1 (MCP-1) from monocytes; in turn, MCP-1 promotes PAH progression by recruiting leukocytes and activating immune cells at sites of vascular inflammation [39,40].